Quick View
| Metric | Current Period | Same Period Previous Year | YoY |
|---|---|---|---|
| Revenue | ¥87.2B | ¥86.1B | +1.3% |
| Operating Income | ¥5.1B | ¥2.2B | +132.4% |
| Ordinary Income | ¥5.0B | ¥2.4B | +112.5% |
| Net Income | ¥3.2B | ¥2.2B | +44.2% |
| ROE | 3.5% | 2.5% | - |
Executive Summary
The cumulative results for Q3 of FY2026 recorded increases in both revenue and earnings, with the particularly significant improvement in operating income being the key feature. Revenue increased modestly to ¥87.2B (+1.3% YoY), while operating income rose substantially to ¥5.1B (+132.4% YoY), ordinary income to ¥5.0B (+112.5% YoY), and net income to ¥3.2B (+44.2% YoY). Earnings growth substantially outpacing revenue growth suggests the emergence of operating leverage through the maintenance of the gross margin and improved SG&A efficiency.
Factors Affecting Performance
【Revenue】Revenue was ¥87.2B, representing modest growth of +1.3% YoY. Although the Company operates as a single Cosmetics Business segment and does not disclose a business-by-business breakdown, progress against the full-year forecast of ¥125.5B was 69.5%, below the standard Q3 progress rate of 75%.
【Profit and Loss】Operating income was ¥5.1B (+132.4% YoY), and the operating margin improved significantly to 5.9% from approximately 2.6% in the previous year. While maintaining a gross margin of 67.1%, SG&A expenses declined to ¥53.3B (equivalent to ¥55.6B in the previous year), with cost efficiencies contributing to the earnings increase. Ordinary income was ¥5.0B (+112.5% YoY), and net income was ¥3.2B (+44.2% YoY); the conversion rate from ordinary income to net income was compressed by the effective tax rate of 36.5%. Extraordinary losses were small at ¥0.005B, indicating limited reliance on temporary factors. Overall, the results can be characterized as an increase in both revenue and earnings.
Segment Analysis
As the Company operates as a single Cosmetics Business segment, segment disclosures have been omitted.
Key Financial Metrics
【Profitability】The operating margin was 5.9%, an improvement of approximately 330bp from approximately 2.6% in the same period of the previous year, while the net margin remained at 3.6%. The gross margin remained high at 67.1%.【Cash Flow Quality】Although Operating Cash Flow (OCF) is not disclosed, cash and deposits were substantial at ¥48.2B, providing high coverage of short-term liabilities. Inventories were significant at ¥15.0B (raw materials: ¥14.0B; finished products: ¥15.0B), with inventory days of 143 days and a CCC of 286 days, confirming the lengthy capital commitment. 【Investment Efficiency】ROE was 3.5%, with both the net margin of 3.6% and total asset turnover of 0.712x acting as constraints. Financial leverage was a conservative 1.35x, limiting the potential for ROE enhancement through the use of debt. 【Financial Soundness】The equity ratio was high at 74.3%, while the current ratio was 388.4%, the quick ratio was 323.9%, and the debt-to-equity ratio was 0.35x, indicating strong short- and long-term financial soundness.
Cash Flow Analysis
As a statement of Operating Cash Flow is not disclosed, funding trends are analyzed based on changes in the balance sheet. Cash and deposits increased to ¥48.2B from ¥47.4B in the previous year, indicating expanded financial capacity. Interest-bearing debt was small at a total of ¥9.5B, comprising short-term borrowings of ¥2.0B and long-term borrowings of ¥7.5B, with the Debt/Capital ratio remaining at 9.5%. Inventories were ¥15.0B, slightly up from ¥14.0B in the previous year. The long-term capital commitment reflected in inventory days of 143 days and a CCC of 286 days was confirmed, and whether the improvement in operating income is translating into actual cash generation should be verified through future OCF disclosures.
Quality of Earnings
The earnings increase for the current period did not depend on extraordinary gains or losses, and extraordinary losses of ¥0.005B were extremely small; therefore, the improvement was primarily driven by recurring operating performance. Non-operating income was ¥0.1B and non-operating expenses were ¥0.2B, making non-operating items a net ¥0.12B factor depressing earnings. In the conversion from ordinary income of ¥5.0B to net income of ¥3.2B, income taxes of ¥1.8B (effective tax rate: 36.5%) were the primary factor, with the tax burden coefficient remaining at 0.634x. Comprehensive income was ¥3.2B, broadly in line with net income, with no significant divergence arising from other comprehensive income items. Meanwhile, the high inventory level (inventories of ¥15.0B and DIO of 280 days) warrants attention from an accrual perspective and may entail future impairment risk.
Earnings Forecast and Guidance
Progress against the full-year forecast varied among profit and loss items. Revenue progress was 69.5% (¥87.2B against the full-year forecast of ¥125.5B), slightly below the standard 75% progress level. Meanwhile, operating income was ¥5.1B, representing progress of 102.6% against the full-year forecast of ¥5.0B, and ordinary income was ¥5.0B, representing progress of 102.2%; both had exceeded their full-year forecasts as of Q3. Net income was ¥3.2B, with progress of only 66.3%, and the likelihood of achieving the full-year target will depend on the tax burden and expense recognition in Q4. The Company has not revised either its earnings forecast or dividend forecast. Notably, the full-year forecast anticipates declines of -15.2% in operating income and -19.5% in ordinary income YoY, requiring attention to the fact that the significant earnings growth in Q3 assumes a reversal in Q4.
Shareholder Returns
The Q2 dividend was ¥0, and the full-year dividend forecast is ¥40 per share, reflecting a policy centered on the year-end dividend. Based on the full-year forecast EPS of ¥126.93, the payout ratio is 31.5% (¥40 ÷ ¥126.93), below the generally accepted guideline for sustainability. No data concerning share repurchases has been disclosed, indicating that shareholder returns consist solely of dividends. Given the financial position of cash and deposits of ¥48.2B and interest-bearing debt of ¥9.5B, constraints on the implementation of the year-end dividend from a profit and funding perspective appear limited.
Risk Factors
-
Inventory Obsolescence Risk: Extended capital commitment is indicated by inventory days of 143 days, DIO of 280 days, and a CCC of 286 days. If the accumulation of inventories of ¥15.0B (including raw materials of ¥14.0B) continues, expiration dates and obsolescence specific to cosmetics could give rise to impairment and discount-selling risks.
-
SG&A Burden Risk: SG&A expenses of ¥53.3B account for approximately 91.2% of gross profit of ¥58.5B, indicating a high fixed-cost ratio. Cost efficiencies amid limited revenue growth of 1.3% were a driver of earnings growth, and sensitivity to operating income may increase if revenue growth slows.
-
Risk of Delayed Net Income Progress: Net income progress against the full-year forecast was 66.3%, lower than the progress rates for operating income and ordinary income (over 100%). Against the backdrop of an effective tax rate of 36.5%, the tax burden and expense recognition in Q4 may affect achievement of the full-year target.
Industry Benchmark (Reference; Compiled by the Company)
Industry Benchmark (manufacturing)
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | 5.9% | 8.6% (4.3%–12.7%) | −2.7pt |
| Net Margin | 3.7% | 6.4% (2.8%–10.3%) | −2.8pt |
Both the operating margin and net margin are below the industry median, indicating that profitability is relatively low within the industry.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | 1.3% | 3.3% (-2.1%–8.9%) | −2.0pt |
The revenue growth rate is also below the industry median, placing top-line expansion somewhat on the weaker side within the industry.
※Source: Compiled by the Company
Key Points in the Earnings Results
-
The operating margin improved by approximately 330bp YoY, and the substantial earnings increase despite revenue growth of only 1.3% indicates the emergence of operating leverage through cost efficiencies. However, compared with the industry median, both the operating margin and net margin remain at low levels.
-
The lengthening of working capital, reflected in inventory days of 143 days and a CCC of 286 days, indicates product accumulation and impairment risk in the Cosmetics Business. This requires monitoring when assessing the sustainability of the improvement in operating income.
-
While progress rates for operating income and ordinary income exceed 100% of their full-year forecasts, net income progress remains at 66.3%. This difference reflects the impact of the tax burden associated with the effective tax rate of 36.5%, and the profit conversion in Q4 will be a key focus in determining full-year performance.
This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly available earnings data. Investment decisions should be made at your own responsibility, and after consulting professionals as necessary.
---End of Report---
AI Financial Analysis
Executive Summary
FY2026 Q3 delivered a material operating-profit recovery, although sales growth remained modest and inventory efficiency is the principal operational constraint. Cumulative revenue rose 1.3% YoY to ¥8.719bn. Operating income increased 132.4% YoY to ¥513m, lifting the operating margin to 5.9% from 2.6%, an expansion of 331bp. Ordinary income rose 112.5% to ¥501m. Net income increased 44.2% to ¥319m, and EPS was ¥84.24. Gross profit declined marginally to ¥5.848bn despite higher sales, with the gross margin contracting 107bp to 67.1% from 68.1%. The much stronger operating result was therefore driven by SG&A discipline rather than gross-margin expansion. SG&A expense fell 5.5% YoY to ¥5.334bn, reducing the SG&A-to-sales ratio by 439bp to 61.2%. The net margin improved 108bp to 3.6%, but its increase lagged operating-margin expansion because the effective tax rate rose to 36.5% from a comparatively low prior-year tax charge. Current-period earnings are predominantly operating in nature, with only ¥0.5m of extraordinary loss. The ¥513m Q3 operating income already exceeds the unchanged ¥500m full-year forecast by 2.6%. Ordinary income also exceeds full-year guidance by 2.2%, whereas revenue progress is 69.5% against the 75% seasonal reference point. The balance sheet is highly liquid, with ¥4.825bn of cash, a 388.4% current ratio, and interest-bearing debt of ¥950m. Financial leverage remains restrained, while interest coverage of 40.76x provides substantial debt-service capacity. Inventory days and the cash conversion cycle remain unusually extended, increasing the importance of sell-through, markdown discipline, and inventory valuation control in the final quarter. The full-year earnings outlook is consequently supported by realized cost savings, but delivery depends on preserving the recovery in operating margin and preventing working-capital inefficiency from developing into inventory write-down pressure.
Profitability Analysis
Annualized DuPont ROE is 4.7%, comprising a 3.6% net profit margin, 0.949x asset turnover, and 1.35x financial leverage. The largest YoY improvement was in profitability: operating margin expanded 331bp to 5.9%, while financial leverage remains low and is not the source of the earnings recovery. Revenue grew only 1.3%, but SG&A fell 5.5%, producing favorable operating leverage and a 439bp reduction in the SG&A ratio to 61.2%. By contrast, gross margin declined 107bp to 67.1%, indicating that the profit rebound did not arise from improved product gross profitability. The 5-factor analysis shows a 0.634 tax burden and 0.977 interest burden; financing costs have limited impact on pre-tax earnings, while tax expense absorbed a greater proportion of profit than in the prior period. Interest expense was ¥12.6m versus EBIT of ¥513m, consistent with the strong 40.76x interest-coverage ratio. The annualized 0.949x asset turnover is moderate, with the cash-rich balance sheet and inventory holdings limiting capital efficiency. Annualized ROE of 4.7% remains below the 8% level commonly associated with an adequate return profile, despite the sharp earnings recovery. Sustainability of the margin improvement depends on whether lower SG&A reflects durable productivity measures rather than temporary reductions in brand-building, customer acquisition, or administrative spending.
Growth Assessment
Revenue growth of 1.3% to ¥8.719bn indicates limited top-line momentum in the cosmetics business. Gross profit decreased 0.3% YoY to ¥5.848bn, confirming that the operating-income recovery was cost-led. The 5.5% reduction in SG&A materially outpaced sales growth and was sufficient to increase operating income by ¥292m YoY. Full-year revenue guidance is ¥12.550bn, implying Q3 cumulative progress of 69.5%, 5.5 percentage points below the standard 75% Q3 run rate. Full-year operating-income guidance of ¥500m has already been exceeded, representing 102.6% progress and 27.6 percentage points above the standard Q3 run rate. Ordinary-income progress is 102.2% against the ¥490m forecast. Net-income progress is 66.4% against the ¥480m forecast, below the 75% seasonal reference point, reflecting the higher current tax burden and the possibility embedded in guidance of a weaker fourth-quarter profit contribution. Management has not revised its forecast, so the implied Q4 outlook is conservative at the operating-profit level or assumes costs, promotional activity, or other expenses will rise. Revenue sustainability should be assessed through the balance between sales growth, gross-margin preservation, and inventory sell-through rather than through the current period's expense reduction alone. The group operates in a single cosmetics segment, making consolidated growth directly dependent on the performance of that core business.
Financial Health
Liquidity is very strong: current assets were ¥9.037bn against current liabilities of ¥2.327bn, producing a 388.4% current ratio and ¥6.710bn of working capital. The 323.9% quick ratio confirms that liquidity is not dependent on inventory realization. Cash and deposits of ¥4.825bn represented 39.4% of total assets and exceeded interest-bearing debt of ¥950m by ¥3.875bn. Debt-to-equity of 0.35x and debt-to-capital of 9.5% indicate a conservative capital structure, well below risk thresholds of 2.0x and 40%, respectively. Long-term loans of ¥750m account for most reported interest-bearing debt, limiting refinancing concentration relative to short-term borrowings. Short-term loans declined ¥300m YoY, or 60.0%, to ¥200m, materially reducing near-term refinancing exposure. Cash covered short-term debt by 24.12x. Total equity increased to ¥9.094bn from ¥8.927bn, supported by retained earnings, and the equity ratio was 74.3%. Total assets declined modestly to ¥12.245bn from ¥12.344bn, while the equity increase and liability reduction strengthened the balance-sheet risk profile. PPE accounts for 23.7% of total assets, while intangible assets are only 0.7%; the asset base therefore carries limited intangible-asset concentration risk. No current-ratio or debt-to-equity warning is triggered.
Notable B/S Changes
Short-term loans: -¥300m (-60.0%) to ¥200m - materially lowers short-term refinancing exposure and reinforces the company's net cash position.
Cash Flow Quality
The financial position supports cash generation capacity, with cash and deposits increasing ¥81m YoY to ¥4.825bn while short-term borrowings fell ¥300m. Working-capital management is the principal cash-quality issue. The quality alerts identify inventory days of 280 days under one reported methodology and 143 days under another annualized methodology; both exceed the relevant 90-day and 60-day warning thresholds. The annualized 143-day measure is consistent with inventory of ¥1.500bn relative to annualized cost of sales, and it remains elevated for a consumer-products business. The reported cash conversion cycle alert of 286 days is also substantially above the 120-day warning threshold. These alerts point to capital being tied up in stock for an extended period, raising vulnerability to slower sell-through, promotional discounting, product obsolescence, or inventory valuation losses. Accounts receivable declined to ¥1.095bn from ¥1.208bn, which is constructive for collection discipline, but the inventory position remains the dominant working-capital consideration. The net cash position provides a substantial buffer against the liquidity consequences of a slower inventory cycle. Sustained improvement in cash conversion requires inventory reduction without sacrificing gross margin through aggressive clearance activity.
Dividend Sustainability
The full-year dividend forecast is ¥40 per share, with no Q2 interim dividend reported. Based on forecast EPS of ¥126.93, the implied dividend payout ratio is approximately 31.5%, below the 60% sustainability benchmark. Using average shares of 3,781,480, the indicated full-year cash dividend is approximately ¥151m, compared with forecast net income of ¥480m. The forecast dividend is therefore covered by forecast earnings by roughly 3.2x. Cash and deposits of ¥4.825bn further support distribution capacity relative to the indicated dividend amount. The balance sheet's low leverage and strong liquidity reduce financial pressure on dividend funding. Dividend sustainability will nonetheless depend on maintaining earnings conversion as the elevated inventory cycle consumes working capital. The unchanged full-year dividend forecast is consistent with a measured capital-return profile rather than an aggressive distribution policy.
Risk Assessment
Business risks include Demand and brand risk: as a single-segment cosmetics business, revenue is exposed to consumer sentiment, competitive product launches, channel conditions, and the effectiveness of marketing investment., Inventory and product-lifecycle risk: reported inventory-day alerts of 280 days and 143 days, together with a 286-day cash conversion cycle alert, create risk of slow-moving stock, markdowns, and potential valuation losses., Gross-margin risk: gross margin fell 107bp to 67.1% despite sales growth, leaving profitability vulnerable if product mix, pricing, input costs, or promotional intensity deteriorate., Cost-recovery risk: the operating-profit improvement was driven primarily by lower SG&A; a resumption of advertising, customer-acquisition, or personnel expenditure could reverse part of the 331bp operating-margin expansion., Industry-specific quality and regulatory risk: cosmetics products face formulation, labeling, safety, and quality-control requirements, and adverse product-quality events can damage brand equity and increase recall-related costs..
Financial risks include Working-capital risk is elevated despite strong liquidity, because prolonged inventory holding periods can delay cash realization and pressure future operating cash generation., Tax-rate risk is relevant to earnings conversion: the effective tax rate was 36.5%, and net-income growth of 44.2% materially trailed operating-income growth of 132.4%., Forecast-execution risk is elevated by the divergence between results and unchanged guidance: operating income has already reached 102.6% of the full-year forecast, while revenue progress is only 69.5%..
Key concerns include Highest priority is the combination of elevated inventory days and a long cash conversion cycle, given its potential effect on cash generation, gross margin, and inventory valuation., The second priority is whether SG&A savings are structurally sustainable without weakening demand generation and brand investment., The third priority is whether the fourth quarter can reconcile the currently strong operating-profit run rate with the unchanged full-year forecast., Balance-sheet leverage and short-term liquidity are not material concerns at present, given the net cash position, 388.4% current ratio, and 40.76x interest coverage..
Investment Implications
Key takeaways include Operating income rose 132.4% YoY to ¥513m on only 1.3% revenue growth, demonstrating strong near-term cost leverage., Operating margin expanded 331bp to 5.9%, but gross margin declined 107bp, so the recovery is not yet supported by better unit economics., Annualized ROE of 4.7% remains modest because net margin and asset turnover are low relative to the sizeable equity base., Cash of ¥4.825bn, low debt, and strong interest coverage provide substantial financial resilience., Inventory efficiency is the central operational variable, with both reported inventory-day alerts above warning thresholds and an elevated cash conversion cycle., The full-year operating-profit forecast has already been exceeded, yet management has not revised guidance..
Metrics to watch include Revenue growth and gross margin, particularly whether the 67.1% gross margin stabilizes or recovers., SG&A-to-sales ratio and the durability of the current 61.2% ratio., Inventory days, inventory balance, and cash conversion cycle., Fourth-quarter operating income relative to the implied full-year guidance outcome., Annualized ROE, net margin, and asset turnover., Dividend execution against the ¥40 per-share full-year forecast..
Regarding relative positioning, The company is financially conservative relative to common liquidity and solvency benchmarks, with exceptionally high current and quick ratios, low debt-to-capital, and strong interest coverage. Operationally, its 5.9% operating margin has improved into a more acceptable range but remains below a 8% benchmark for a strong profitability profile, while annualized ROE of 4.7% and elevated inventory-cycle indicators point to weaker capital efficiency.